Events

Cancer Mission Matchmaking Event - 2027 Calls

When
JAN ’27
Wed
20

09:00 - 17:00

Starts 2 months from now

Location

Online

Programmes
  • Health
  • Missions

This online brokerage event is aimed at stakeholders that are preparing the 2027 Horizon Europe Cancer Mission topics. The event aims to bring together call insight, structured capability mapping and facilitated introductions of potential partners.

EIT Global Outreach, in collaboration with the UK Health NCPs based at UKRI, organises an online brokerage event on selected 2027 Horizon Europe Cancer Mission topics. It aims to help participants present their capabilities, identify partner needs and explore potential roles in consortia.

Participants can expect:

  • an overview of the selected 2027 Cancer Mission topics,
  • guidance on forming Horizon Europe partnerships and presenting organisational capability,
  • breakout introductions with relevant organisations.


Registered participants are mapped by topic, capability, desired role and partner need, and the organisers may facilitate follow-up introductions after the session.

Interested to participate? Find more information here. Participation is free of charge; registration is required here. Registration deadline is 13 December 2026.

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Event calendar

  • Joint Research Center
  • Defence

Annual Research Conference 2026: Defence and economic security for a stronger and more independent Europe

NOV
Thu
12

The Annual Research Conference (ARC) bridges academic research and European policymaking, bringing research findings directly to the European Commission. Organised jointly by the Directorate-General for Economic and Financial Affairs (DG ECFIN) and the Joint Research Centre (JRC), the ARC addresses a different topic each year to inform...

Read more
  • Defence
  • EDF
  • NATO-EDA
  • DIRS

Control of strategic goods: Basic training dual-use goods

NOV
Thu
12

Attendees can expect to gain insights into regulations and best practices on dual-use goods relevant to their sectors. Two online sessions of this basic training on dual-use goods are planned on 26 February and 12 November 2026 from 9:30 to 11:45. One physical session is planned on 10 June in the offices of the Strategic Goods Control Unit...

Read more
  • Horizon Europe
  • HorizonEU L+F

Lump Sum Funding in Horizon Europe

NOV
Thu
12

The European Commission is organising a YouTube webinar about Lump Sum Funding in Horizon Europe (HEU) "Lump Sum Funding in HEU: How does it work? How to write a proposal?", including sharing of practical experiences. The link to the programme and the webinar can be found here. No prior registration is needed. You can also go...

Read more
  • Horizon Europe
  • HorizonEU L+F

EU - Webinar: IP & Open Science

NOV
Thu
12

This webinar targets early career researchers and looks at the basics of intellectual property and open science. It aims to show how IP rules and open science practices can work together, and explains that open access does not remove IP considerations or automatically allow commercial use. The session is organised by the European Innovation Council and SMEs Executive Agency through the European IP Helpdesk.

Read more

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.